Considerations for CTO Stenting
Characteristics for Stenting a CTO LesionHear his perspective
For health care professionals in EUROPE excepted those practicing in France as the following pages are intended to all International health care professionals and are not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011 article 34. Other health care professionals should select their country in the top right corner of the website.
Please note that the following pages are exclusively reserved for health care professionals in countries with applicable health authority product registrations. To the extent this site contains information, reference guides and databases intended for use by licensed medical professionals, such materials are not intended to offer professional medical advice. Prior to use, please consult device labeling for prescriptive information and operating instructions.
This Website is protected by the laws on copyright and by the relevant international conventions. It is strictly forbidden to make copies, whether partial or total and on whichever media without prior approval.
The SYNERGY Stent is indicated for treatment of patients presenting with coronary artery total occlusion lesions and has a labeled overexpansion of up to 5.75mm allowing the physician to customize the stent to the appropriate vessel size.
SYNERGY Stent System DFU
The SYNERGY Stent’s customized architecture offers exceptional strength and conformability.
Radial Strength: Amount of radial force required to reduce the diameter of a deployed stent by 15%
Conformability: The amount of torque required to bend the stent to a specific curvature
The SYNERGY Stent’s bioabsorbable polymer and abluminal coating are designed for early healing as the polymer is gone when no longer needed, shortly after completion of drug elution at 3 months.
Wilson, G.J., et al. Catheter Cardiovasc Interv. 2015.
Results from case studies are not necessarily predictive of results in other cases. Results in other cases may vary.
Boston Scientific is committed to supporting studies evaluating the SYNERGY Stent in patient populations that interventional Cardiologists see in their everyday practice, including CTO stenting.